The GLOW Pregnancy Registry

Are you pregnant and diagnosed with plaque psoriasis?

Have you used SKYRIZI® (risankizumab-rzaa) or other medications for plaque psoriasis during your pregnancy or just prior to becoming pregnant?

Plaque psoriasis is a complex and chronic condition that can be debilitating. Help future pregnant women, doctors, and researchers understand the safety of medications that can provide some relief.

Are you a healthcare provider who treats pregnant women with plaque psoriasis?

Help us learn more about the safety of using SKYRIZI® (risankizumab-rzaa) and other plaque psoriasis medications during pregnancy.

This website is supported by AbbVie Clinical Development Operations.

The GLOW Pregnancy Registry

Many pregnant women take medications during pregnancy, either knowingly or before they know they are pregnant. Since pregnant women are excluded from most research studies, little is known about the safety of medication use during pregnancy. Pregnancy registries collect health information on pregnant women and their newborn babies. This information can then be used to help doctors and patients make informed decisions about medication use during pregnancy.

The goal of the GLOW Pregnancy Registry is to help doctors, patients, and researchers better understand the safety of SKYRIZI® (risankizumab-rzaa) and other plaque psoriasis medications when used during pregnancy. Pregnant women in the United States with plaque psoriasis may be eligible to participate. The study collects health information from enrolled pregnant women and their healthcare providers related to their pregnancies and developing babies up to 1 year of age.

Would you like to participate?

Enroll in the Registry

What is SKYRIZI® (risankizumab-rzaa)?

SKYRIZI® (risankizumab-rzaa) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).


SKYRIZI® (risankizumab-rzaa) may cause serious side effects, including:

  • Serious allergic reactions: Stop using SKYRIZI® (risankizumab-rzaa) and get emergency medical help right away if you get any symptoms of a serious allergic reaction.
  • Infections: SKYRIZI® (risankizumab-rzaa) may increase your risk of infections. Before starting treatment, your doctor should check you for infections and tuberculosis. Tell your doctor right away if you have an infection or symptoms of one.

Do not use SKYRIZI® (risankizumab-rzaa) if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI®.

Also, tell your doctor if you plan to or recently received a vaccine.

Please see the Full Prescribing Information, including the Medication Guide, for SKYRIZI® (risankizumab-rzaa).

Learn more about the Registry

GLOW Pregnancy Registry toll-free number 1-877-302-2161